Scientific Board

Geoffrey Burgess, MD

Dr. Burgess is currently Chief Medical Officer at IWel Health. Dr. Burgess just retired after 40 years practice as a family medicine specialist with focus on diabetes in west Philadelphia area. Dr. Burgess graduated from Pennsylvania State University College of Medicine in 1975. Dr. Burgess founded Gateway Medical Associates in 1986 and worked as Medical Director at Tandigm Health from 2014 to 2017.

Michael A Friedman, MD

Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy.  He served as President and CEO of City of Hope, a leading cancer research, treatment and education institution, as well as director of the organization’s Comprehensive Cancer Center.  Before that, Dr. Friedman was SVP of R&D, medical and public policy for Pharmacia Corp.  Dr. Friedman previously served as deputy commissioner for the U.S. FDA, later serving as acting commissioner.  Dr. Friedman holds a MD degree from the University of Texas and received his bachelor’s degree from Tulane University.

Dr. Friedman currently serves on the board of Mannkind, Cytovia, Sermonix and as a trustee of Tulane University and on the California Stem Cell Oversight Board.  He has served as a nonexecutive director on the boards of the Celgene, Smith and Nephew, and Intuitive Surgical.

Scroll to Top